224 related articles for article (PubMed ID: 27123695)
21. A Study of the Effect of Cyclosporine on Fevipiprant Pharmacokinetics and its Absolute Bioavailability Using an Intravenous Microdose Approach.
Weiss HM; Umehara KI; Erpenbeck VJ; Cain M; Vemula J; Elbast W; Zollinger M
Drug Metab Dispos; 2020 Oct; 48(10):917-924. PubMed ID: 32739890
[TBL] [Abstract][Full Text] [Related]
22. Gender-related pharmacokinetics and absolute bioavailability of diosbulbin B in rats determined by ultra-performance liquid chromatography-tandem mass spectrometry.
Yang B; Wang X; Liu W; Zhang Q; Chen K; Ma Y; Wang C; Wang Z
J Ethnopharmacol; 2013 Oct; 149(3):810-5. PubMed ID: 23954278
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of 14C-radioactivity after oral intake of a single dose of 14C-labeled fampridine (4-aminopyridine) in healthy volunteers.
Blight AR; Henney HR
Clin Ther; 2009 Feb; 31(2):328-35. PubMed ID: 19302905
[TBL] [Abstract][Full Text] [Related]
24. Determination of the absolute bioavailability of oral imatinib using a stable isotopically labeled intravenous imatinib-d8 microdose.
Roosendaal J; Groenland SL; Rosing H; Lucas L; Venekamp N; Nuijen B; Huitema ADR; Beijnen JH; Steeghs N
Eur J Clin Pharmacol; 2020 Aug; 76(8):1075-1082. PubMed ID: 32430518
[TBL] [Abstract][Full Text] [Related]
25. A Phase 1 Study to Evaluate Absolute Bioavailability and Absorption, Distribution, Metabolism, and Excretion of Savolitinib in Healthy Male Volunteers.
Miah K; Vishwanathan K; Scarfe G; Li Y; Hara I; Cantarini M; Argue J; Menakuru SR
Clin Pharmacol Drug Dev; 2023 Apr; 12(4):424-435. PubMed ID: 36808891
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and disposition of carvedilol in humans.
Neugebauer G; Akpan W; von Möllendorff E; Neubert P; Reiff K
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S85-8. PubMed ID: 2454375
[TBL] [Abstract][Full Text] [Related]
27. An Innovative Approach to Characterize Clinical ADME and Pharmacokinetics of the Inhaled Drug Nemiralisib Using an Intravenous Microtracer Combined with an Inhaled Dose and an Oral Radiolabel Dose in Healthy Male Subjects.
Harrell AW; Wilson R; Man YL; Riddell K; Jarvis E; Young G; Chambers R; Crossman L; Georgiou A; Pereira A; Kenworthy D; Beaumont C; Marotti M; Wilkes D; Hessel EM; Fahy WA
Drug Metab Dispos; 2019 Dec; 47(12):1457-1468. PubMed ID: 31649125
[TBL] [Abstract][Full Text] [Related]
28. The effects of dose, route, and repeated dosing on the disposition and kinetics of tetrabromobisphenol A in male F-344 rats.
Kuester RK; Sólyom AM; Rodriguez VP; Sipes IG
Toxicol Sci; 2007 Apr; 96(2):237-45. PubMed ID: 17234645
[TBL] [Abstract][Full Text] [Related]
29. Disposition, oral bioavailability, and tissue distribution of zearalenone in rats at various dose levels.
Shin BS; Hong SH; Bulitta JB; Hwang SW; Kim HJ; Lee JB; Yang SD; Kim JE; Yoon HS; Kim DJ; Yoo SD
J Toxicol Environ Health A; 2009; 72(21-22):1406-11. PubMed ID: 20077212
[TBL] [Abstract][Full Text] [Related]
30. Population Pharmacokinetic and Exposure-dizziness Modeling for a Metabotropic Glutamate Receptor Subtype 5 Negative Allosteric Modulator in Major Depressive Disorder Patients.
Cosson V; Schaedeli-Stark F; Arab-Alameddine M; Chavanne C; Guerini E; Derks M; Mallalieu NL
Clin Transl Sci; 2018 Sep; 11(5):523-531. PubMed ID: 29877614
[TBL] [Abstract][Full Text] [Related]
31. Microdose pharmacokinetics of IDX899 and IDX989, candidate HIV-1 non-nucleoside reverse transcriptase inhibitors, following oral and intravenous administration in healthy male subjects.
Zhou XJ; Garner RC; Nicholson S; Kissling CJ; Mayers D
J Clin Pharmacol; 2009 Dec; 49(12):1408-16. PubMed ID: 19776293
[TBL] [Abstract][Full Text] [Related]
32. The Absolute Bioavailability, Absorption, Distribution, Metabolism, and Excretion of BI 425809 Administered as an Oral Dose or an Oral Dose with an Intravenous Microtracer Dose of [
Burkard U; Desch M; Shatillo Y; Wunderlich G; Mack SR; Schlecker C; Teitelbaum AM; Liu P; Chan TS
Clin Drug Investig; 2022 Jan; 42(1):87-99. PubMed ID: 34936055
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics, Excretion, and Mass Balance of [
Ambery C; Young G; Fuller T; Lazaar AL; Pereira A; Hughes A; Ramsay D; van den Berg F; Daley-Yates P
Clin Pharmacol Drug Dev; 2018 Nov; 7(8):901-910. PubMed ID: 30230263
[TBL] [Abstract][Full Text] [Related]
34. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
35. Metabolism and disposition of vatalanib (PTK787/ZK-222584) in cancer patients.
Jost LM; Gschwind HP; Jalava T; Wang Y; Guenther C; Souppart C; Rottmann A; Denner K; Waldmeier F; Gross G; Masson E; Laurent D
Drug Metab Dispos; 2006 Nov; 34(11):1817-28. PubMed ID: 16882767
[TBL] [Abstract][Full Text] [Related]
36. Absorption, distribution, metabolism and excretion (ADME) of the ALK inhibitor alectinib: results from an absolute bioavailability and mass balance study in healthy subjects.
Morcos PN; Yu L; Bogman K; Sato M; Katsuki H; Kawashima K; Moore DJ; Whayman M; Nieforth K; Heinig K; Guerini E; Muri D; Martin-Facklam M; Phipps A
Xenobiotica; 2017 Mar; 47(3):217-229. PubMed ID: 27180975
[TBL] [Abstract][Full Text] [Related]
37. Disposition of [14C]avitriptan in rats and humans.
Marathe PH; Greene DS; Barbhaiya RH
Drug Metab Dispos; 1997 Jul; 25(7):881-8. PubMed ID: 9224783
[TBL] [Abstract][Full Text] [Related]
38. Oral bioavailability and disposition characteristics of irbesartan, an angiotensin antagonist, in healthy volunteers.
Vachharajani NN; Shyu WC; Chando TJ; Everett DW; Greene DS; Barbhaiya RH
J Clin Pharmacol; 1998 Aug; 38(8):702-7. PubMed ID: 9725545
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics, metabolism and pharmacodynamics of a benzimidazole angiotensin II type 1 receptor antagonist in the beagle dog and cynomologus monkey.
Kakiki M; Ishihara H
Xenobiotica; 1998 Jan; 28(1):77-91. PubMed ID: 9493321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
